J8515 Cabergoline, oral 0.25mg
Also known as: Dostinex, Oral cabergoline
Cabergoline administered orally at 0.25 milligrams per dose; a dopamine agonist used to suppress prolactin secretion.
In Plain Language
Prolactin-lowering pill; Pituitary hormone medication
Clinical Context
Used for treatment of hyperprolactinemia and prolactin-secreting pituitary adenomas. More selective dopamine agonist than bromocriptine.
RVU Information
CPT J8515 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J8515?
CPT J8515 (Cabergoline, oral 0.25mg) is a J Codes (Drugs) code. Cabergoline administered orally at 0.25 milligrams per dose; a dopamine agonist used to suppress prolactin secretion.
How is J8515 administered?
CPT J8515 is administered by a healthcare provider, typically via injection or infusion. Used for treatment of hyperprolactinemia and prolactin-secreting pituitary adenomas. More selective dopamine agonist than bromocriptine. It is used by Endocrinology, Neurosurgery, Gynecology.
When is CPT J8515 used?
Used for treatment of hyperprolactinemia and prolactin-secreting pituitary adenomas. More selective dopamine agonist than bromocriptine.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.